gadolinium has been researched along with ioversol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, KT; Gierada, DS | 1 |
| Huang, D; Huang, Y; Jiang, C; Jiang, X; Li, J; Lin, J | 1 |
2 other study(ies) available for gadolinium and ioversol
| Article | Year |
|---|---|
Gadolinium as a CT contrast agent: assessment in a porcine model.
Topics: Animals; Aortography; Contrast Media; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Injections, Intravenous; Kidney; Liver; Lung; Pulmonary Artery; Radiographic Image Enhancement; Safety; Swine; Time Factors; Tomography, X-Ray Computed; Triiodobenzoic Acids | 1999 |
Clinical safety evaluation of contrast agents based on real-world evidence.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Sex Factors; Tomography, X-Ray Computed; Triiodobenzoic Acids; Young Adult | 2021 |